Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

ClinicalTrials.gov ID: NCT04271514

Public ClinicalTrials.gov record NCT04271514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-dose Escalation, Multiple-dose Escalation, and Food Effect Study of RPT193 in Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis

Study identification

NCT ID
NCT04271514
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
RAPT Therapeutics, Inc.
Industry
Enrollment
103 participants

Conditions and interventions

Interventions

  • RPT193 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 11, 2019
Primary completion
Apr 25, 2021
Completion
Apr 25, 2021
Last update posted
Sep 29, 2021

2019 – 2021

United States locations

U.S. sites
13
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Pinnacle Research Group, LLC Anniston Alabama 36207
Perseverance Research Center LLC Scottsdale Arizona 85254
University Clinical Trials, Inc San Diego California 92123
Lenus Research & Medical Group Miami Florida 33172
ForCare Clinical Research Tampa Florida 33613
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
DelRicht Research Baton Rouge Louisiana 70809
Clinical Trials Management,LLC Metairie Louisiana 70006
MetroBoston Clinical Partners LLC Brighton Massachusetts 02135
Sadick Research Group LLC New York New York 10075
Central Sooner Research Norman Oklahoma 73071
DermResearch, Inc. Austin Texas 78759
Progressive Clinical Research PA San Antonio Texas 78213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04271514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04271514 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →